Caplight Directory>Companies>Fluid Biomed-preview>Fluidbiomed


Fluid Biomed

Fluid Biomed

Private
Calgary, AlbertaHealthcare & Life Scienceshttps://fluidbiomed.com/

Last Round

Series A

Dec 16, 2024

Total Funding Raised

$31.7M

Company Overview

Fluid Biomed is a medical device company that develops a bioabsorbable, polymer-based stent called ReSolv™ to treat brain aneurysms.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

bioabsorbable stentflow-diverting stentbrain aneurysm treatmentneurovascular stentdissolvable stentresorbable stentflow divertermedtechpolymer stentmedical deviceendovascular procedureminimally invasive devicestroke preventioninterventional neuroradiologyclinical-stage company

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fluid Biomed Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Fluid Biomed Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series ADec 16, 2024
SeedAug 11, 2021
View all Funding Rounds

Key People

Founding team and executive leadership

John Wong

Co-Founder And CEO

Founding Team

Fluid Biomed Investors

Notable investors and investment history

InvestorRounds
IAG Capital PartnersSeries A
Wharton Alumni AngelsSeed
Amplitude VenturesSeries A
Amino CapitalSeed
UCeed Health FundSeed
LifeArc VenturesSeries A
ShangBay CapitalSeries A, Seed
View all Investors

Fluid Biomed Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fluid Biomed Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fluid Biomed's valuation, stock price, and market status.

Firmographic Details

HeadquartersCalgary, Alberta
Employee Range37
Year Founded2012
Last FundingDec 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.